Department of Medicine and Health, the University of Sydney, Sydney, NSW, Australia
Case Report
Position Paper on Management and Shared Decision-making in Patients with Low-risk Micro Papillary Thyroid Carcinoma from the Endocrine Task Force of the European Organization for Research and Treatment of Cancer
Author(s): Frans Geenen*
Globally, there has been an increase in the incidence of differentiated thyroid cancer (DTC), primarily due to an increase in the incidental discovery of micro papillary thyroid carcinomas (microPTCs), many of which may have received unnecessary treatment based on the unchanging mortality rate. A less combative strategy has been recommended by several international guidelines. Active surveillance or minimally invasive therapies (MIT) have lately been proven to be effective alternatives for the management of these individuals. Participation of the patient in the decision-making process is crucial in this situation. The European Organization for Research and Treatment of Cancer's Endocrine Task Force (EORTC) has taken on the task of reaching agreement and defining its position based on the scientific evidence regarding 1) the current state of diagnostic and management options in mic.. View More»
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 